-
1 Comment
The Flowr Corporation is currently in a long term downtrend where the price is trading 37.4% below its 200 day moving average.
From a valuation standpoint, the stock is 99.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.3.
The Flowr Corporation's total revenue rose by 110.0% to $3M since the same quarter in the previous year.
Its net income has increased by 35.8% to $-10M since the same quarter in the previous year.
Finally, its free cash flow grew by 58.5% to $-10M since the same quarter in the previous year.
Based on the above factors, The Flowr Corporation gets an overall score of 4/5.
Exchange | V |
---|---|
CurrencyCode | CAD |
ISIN | CA34354X1087 |
Industry | Pharmaceuticals |
Sector | Healthcare |
Target Price | 0.02 |
---|---|
Market Cap | 11M |
PE Ratio | None |
Beta | 0.5 |
Dividend Yield | 0.0% |
The Flowr Corporation cultivates, produces, and sells cannabis in Canada. The company offers dried flowers and pre-rolls. It also has operations in Canada, Portugal, and the European Union. The company was incorporated in 2016 and is headquartered in Toronto, Canada.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for FLWR.V using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025